Home AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal
 

Keywords :   


AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal

2015-03-05 13:11:44| Biotech - Topix.net

AbbVie Inc is to buy Pharmacyclics Inc for about $21 billion, giving it access to what is expected to be one of the world's top-selling cancer drugs and expanding its reach in the profitable oncology field. The deal -- the latest example of a big drugmaker swooping on a biotech firm to refill its medicine pipeline -- confounds expectations that Pharmacyclics would sell out to Johnson & Johnson .

Tags: deal drug cancer billion

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.11 FCS HARLEY INGLEBY QUAD HI
14.11
14.11FRTC21 530 Panasonic
14.11THE NORTH FACE Evacargo 2 1
14.11THE LYRICS
14.11Nintendo Switch GUITAR LIFE LESSON 1
14.11Umbro
14.112
More »